Table 2:
n (column %)1 | LOS n=786 | LOCNC n=1601 | Unaffected n=1553 | p-value2 |
---|---|---|---|---|
Infants with cranial imaging, N | 781 | 1597 | 1547 | |
IVH any grade | 295 (37.9) | 525 (33.0) | 447 (28.9) | <0.001 |
Severe IVH | 167 (21.5) | 262 (16.5) | 225 (14.6) | <0.001 |
Severe IVH diagnosed within 7 days of birth | 48 (6.2) | 77 (4.8) | 89 (5.8) | 0.33 |
Ventriculomegaly | 200 (25.6) | 334 (20.9) | 242 (15.6) | <0.001 |
Cerebellar hemorrhage3 | 7/291 (2.4) | 19/717 (2.6) | 11/794 (1.4) | 0.20 |
Periventricular leukomalacia | 39 (5.0) | 96 (6.0) | 54 (3.5) | 0.004 |
Porencephalic cyst | 14 (1.8) | 45 (2.8) | 29 (1.9) | 0.13 |
Brain injury4 | 228 (29.3) | 381 (23.9) | 290 (18.8) | <0.001 |
Survived in-hospital at 28 d, N | 634 | 1490 | 1414 | |
Had ROP exam | 609 | 1456 | 1390 | |
ROP | 474 (77.8) | 1100 (75.5) | 883 (63.5) | <0.001 |
ROP stage 3 or worse | 137 (22.5) | 319 (21.9) | 194 (14.0) | <0.001 |
Survived to status5, N | 598 | 1449 | 1412 | |
Had ROP assessed | 586 | 1414 | 1343 | |
Severe ROP 6 | 76 (13.0) | 187 (13.2) | 87 (6.5) | <0.001 |
Survived to 36 weeks PMA, N | 602 | 1459 | 1414 | |
BPD 7 | 361 (60.2) | 957 (66.0) | 667 (47.5) | <0.001 |
BPD, bronchopulmonary dysplasia. IVH, intraventricular hemorrhage. LOS, late-onset sepsis. LOCNC, late-onset blood culture-negative condition. PMA, post-menstrual age. PVL, periventricular leukomalacia. ROP, retinopathy of prematurity.
Information was missing for (n) infants: IVH (9); PVL (1); porencephalic cyst (1); brain injury (6); BPD, (21).
P-value by chi-square test.
Cerebellar hemorrhage was collected beginning April 2011.
Brain injury was defined as one or more of the following findings on cranial imaging: severe IVH, PVL, ventriculomegaly, porencephalic cyst, or cerebellar hemorrhage.
Includes infants discharged home or transferred before 120 days or still in the hospital at 120 days.
ROP determined was considered severe if either eye met one of the following criteria: had ROP surgery, anti-VEGF injection, or retinal detachment from ROP.
BPD was defined as oxygen use at 36 weeks PMA.